HLN logo

Haleon (HLN)

Profile

Full Name

Haleon plc

Ticker Symbol

HLN

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United Kingdom

IPO

July 25, 2022

Indexes

Not included

Website

http://www.haleon.com

Employees

24561

Key Details

Price

$10.12(+0.10%)

Market cap

Last Dividend

$0.05

TTM Dividend yield

0.52%

Annual revenue

$14.36B(+2.08% YoY)

Annual EPS

$0.40(+42.71% YoY)

PE ratio

25.16

Next earnings date

Jul 31, 2025

Next ex-dividend date

Apr 25, 2025

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.12
HLN price is $10.12

30-Day Relative Volume

1.19
HLN 30-day relative volume is 1.19

Price Performance

Price Most recent change

+0.1%
HLN price was up +0.1% on Apr 15, 2025

Price YTD change

+6.08%
HLN price is up +6.08% since January 1st

Price 1-year change

+24.94%
HLN price is up +24.94% year-on-year

Price 3-year change

-
HLN price 3-year change is unknown

Price Range

Price All-time high

$10.80
HLN price is currently -6.30% below its historical high of $10.80

Price 3-year low

$5.59
HLN price is currently +81.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$45.72B
HLN market capitalization is $45.72 billion

Market cap 3-year change

-
HLN market capitalization 3-year change is unknown

Market cap All-time high

$49.07B
HLN market capitalization is currently -6.83% below its historical high of $49.07 billion

Market cap sector rank

97.45%
HLN market capitalization is higher than 97.45% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.95%
HLN shares outstanding is down -0.95% year-on-year

Shares Outstanding 3-Year Change

-
HLN shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.21
HLN beta is 0.21

200-day SMA

$9.76
HLN price is currently +3.64% above its 200-day simple moving average

50-day SMA

$10.06
HLN price is currently +0.60% above its 50-day simple moving average

RSI

52.56
HLN 14-day relative strength index is 52.56

Volume

1.19
HLN 30-day relative volume is 1.19

ATR

$0.27
HLN average true range is $0.27

10-day Historical Volatility

54.87%
HLN 10-day historical volatility is 54.87%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.05
HLN last dividend was $0.05 per share, with an ex-dividend date of August 16, 2024

Next Dividend

$0.12
HLN has announced a dividend of $0.12 per share, with an ex-dividend date set for April 25, 2025

Dividend per share

Dividend per share

$0.16
HLN annual dividend per share is $0.16

Dividend per share Sector Rank

8.14%
HLN annual dividend per share is higher than 8.14% of companies in Healthcare sector

Dividend per share 1-Year Change

+52.51%
HLN annual dividend per share is up +52.51% year-on-year

Dividend per share 3-Year Change

-
HLN annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

1.56%
HLN annual dividend yield is 1.56%

Dividend yield Sector Rank

40%
HLN annual dividend yield is higher than 40% of companies in Healthcare sector

Other

Payout ratio

39.53%
HLN annual payout ratio is 39.53%

Dividends paid

$728.48M
HLN annual dividends paid is $728.48 million

Free cash flow

$2.53B
HLN annual free cash flow is $2.53 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$14.36B
HLN annual revenue is $14.36 billion

Revenue Analysts estimate

$11.42B
HLN annual revenue is currently +25.71% higher than the consensus analysts' forecast

Revenue 1-year change

+2.08%
HLN annual revenue is up +2.08% year-on-year

Revenue Sector rank

95.42%
HLN annual revenue is higher than 95.42% of companies in Healthcare sector

EPS

EPS

$0.40
HLN annual earnings per share is $0.40

EPS Analysts estimate

$0.41
HLN annual earnings per share is currently -1.45% lower than the consensus analysts' forecast

EPS 1-year change

+42.71%
HLN annual earnings per share is up +42.71% year-on-year

EPS Sector rank

86.58%
HLN annual earnings per share is higher than 86.58% of companies in Healthcare sector

Profit

Gross profit

$8.72B
HLN annual gross profit is $8.72 billion

Gross margin

60.75%
HLN annual gross profit margin is 60.75%

Operating profit

$2.82B
HLN annual operating income is $2.82 billion

Operating margin

19.64%
HLN annual operating profit margin is 19.64%

Net income

$1.84B
HLN annual net profit is $1.84 billion

Net margin

12.84%
HLN annual net profit margin is 12.84%

Expenses

Total expenses

$11.54B
HLN annual total expenses is $11.54 billion

Operating expenses

$5.90B
HLN annual total operating expenses is $5.90 billion

Cost of goods sold

$5.63B
HLN annual cost of goods sold is $5.63 billion

Selling, general & administrative expenses

$5.69B
HLN annual SGA is $5.69 billion

Depreciation and amortization

$414.08M
HLN annual depreciation & amortization is $414.08 million

Interest expense

$490.77M
HLN annual interest expense is $490.77 million

Income tax

$555.95M
HLN annual income tax is $555.95 million

EBIT & EBITDA

EBIT

$2.93B
HLN annual earnings before interest & taxes is $2.93 billion

EBITDA

$3.35B
HLN annual EBITDA is $3.35 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$43.06B
HLN annual total assets is $43.06 billion

Non current assets

$35.88B
HLN annual long term assets is $35.88 billion

Current assets

$7.17B
HLN annual total current assets is $7.17 billion

Cash and cash equivalents

$2.82B
HLN annual cash & cash equivalents is $2.82 billion

Accounts receivable

$2.58B
HLN annual accounts receivable is $2.58 billion

Inventory

$1.49B
HLN annual inventory is $1.49 billion

Liabilities

Total liabilities

$22.70B
HLN annual total liabilities is $22.70 billion

Long term liabilities

$15.41B
HLN annual total long term liabilities is $15.41 billion

Current liabilities

$7.29B
HLN annual total current liabilities is $7.29 billion

Accounts payable

$4.65B
HLN annual accounts payable is $4.65 billion

Debt

Total debt

$12.71B
HLN annual total debt is $12.71 billion

Total debt 1-year change

+5.49%
HLN annual total debt is up +5.49% year-on-year

Long term debt

$10.84B
HLN annual long term debt is $10.84 billion

Short term debt

$1.87B
HLN annual short term debt is $1.87 billion

Equity & Capital

Shareholders equity

$20.28B
HLN annual stockholders equity is $20.28 billion

Book value

$20.28B
HLN annual book value is $20.28 billion

Retained earnings

$34.22B
HLN annual retained earnings is $34.22 billion

Working capital

-$117.95M
HLN annual working capital is -$117.95 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$2.94B
HLN annual cash flow from operations is $2.94 billion

Cash from operations 1-year change

+12.54%
HLN annual cash flow from operations is up +12.54% year-on-year

Cash from investing

$674.80M
HLN annual cash flow from investing activities is $674.80 million

Cash from investing 1-year change

+504.71%
HLN annual cash flow from investing activities is up +504.71% year-on-year

Cash from financing

-$1.96B
HLN annual cash flow from financing activities is -$1.96 billion

Cash from financing 1-year change

-0.68%
HLN annual cash flow from financing activities is down -0.68% year-on-year

CAPEX

CAPEX

$406.42M
HLN annual capital expenditures is $406.42 million

CAPEX 1-year change

-2.79%
HLN annual capital expenditures is down -2.79% year-on-year

Free Cash Flow

Free cash flow

$2.53B
HLN annual free cash flow is $2.53 billion

Free cash flow 1-year change

+15.46%
HLN annual free cash flow is up +15.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

60.75%
HLN annual gross profit margin is 60.75%

Operating margin

19.64%
HLN annual operating profit margin is 19.64%

Net margin

12.84%
HLN annual net profit margin is 12.84%

ROA & ROE

ROA

4.26%
HLN annual return on assets is 4.26%

ROE

8.85%
HLN annual return on equity is 8.85%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

25.16
HLN price to earnings ratio is 25.16

PE ratio Sector rank

51.47%
HLN price to earnings ratio is higher than 51.47% of companies in Healthcare sector

PB Ratio

PB ratio

2.25
HLN price to book ratio is 2.25

PB ratio Sector rank

66.09%
HLN price to book ratio is higher than 66.09% of companies in Healthcare sector

PS Ratio

PS ratio

3.19
HLN price to sales ratio is 3.19

PS ratio Sector rank

54.23%
HLN price to sales ratio is higher than 54.23% of companies in Healthcare sector

Enterprise value

Enterprise value

$55.64B
HLN enterprise value is $55.64 billion

Enterprise value Sector rank

97.52%
HLN enterprise value is higher than 97.52% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.96
HLN EV/EBITDA is 18.96

EV/EBITDA Sector rank

91.12%
HLN EV/EBITDA is higher than 91.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.98
HLN annual current ratio is 0.98

Quick ratio

0.78
HLN annual quick ratio is 0.78

Leverage

Debt to equity

0.63
HLN annual debt to equity ratio is 0.63

Interest coverage ratio

5.97
HLN annual interest coverage ratio is 5.97

Risk & Stability

Piotroski F-Score

-
HLN piotroski f-score value is unknown

Altman Z-Score

2.88
HLN altman z-score is 2.88

Analyst ratings

Recent major analysts updates

Sep 20, 24 Morgan Stanley
Overweight
Mar 26, 24 Argus Research
Buy
Nov 1, 23 Morgan Stanley
Overweight
Apr 6, 23 Argus Research
Buy
Sep 28, 22 Argus Research
Hold
Jul 29, 22 Deutsche Bank
Hold

Institutional Ownership

Similar stocks

TAK logo
Takeda Pharmaceutical Company Limited (TAK)
ALC logo
Alcon (ALC)
EW logo
Edwards Lifesciences (EW)
ARGX logo
argenx SE (ARGX)
VEEV logo
Veeva Systems (VEEV)
HUM logo
Humana (HUM)
BDX logo
Becton Dickinson and Company (BDX)
IDXX logo
IDEXX Laboratories (IDXX)
CAH logo
Cardinal Health (CAH)
  • What is the ticker symbol for Haleon?
  • Does Haleon pay dividends?
  • What sector is Haleon in?
  • What industry is Haleon in?
  • What country is Haleon based in?
  • When did Haleon go public?
  • Is Haleon in the S&P 500?
  • Is Haleon in the NASDAQ 100?
  • Is Haleon in the Dow Jones?
  • When was Haleon's last earnings report?
  • When does Haleon report earnings?

What is the ticker symbol for Haleon?

The ticker symbol for Haleon is NYSE:HLN

Does Haleon pay dividends?

Yes, Haleon pays dividends. The last payment was $0.05, with an ex-dividend date on August 16, 2024

What sector is Haleon in?

Haleon is in the Healthcare sector

What industry is Haleon in?

Haleon is in the Drug Manufacturers - Specialty & Generic industry

What country is Haleon based in?

Haleon is headquartered in United Kingdom

When did Haleon go public?

Haleon's initial public offering (IPO) was on July 25, 2022

Is Haleon in the S&P 500?

No, Haleon is not included in the S&P 500 index

Is Haleon in the NASDAQ 100?

No, Haleon is not included in the NASDAQ 100 index

Is Haleon in the Dow Jones?

No, Haleon is not included in the Dow Jones index

When was Haleon's last earnings report?

Haleon's most recent earnings report was on Feb 27, 2025

When does Haleon report earnings?

The next expected earnings date for Haleon is Jul 31, 2025
On this page